PUBLISHER: Fortune Business Insights Pvt. Ltd. | PRODUCT CODE: 1884048
PUBLISHER: Fortune Business Insights Pvt. Ltd. | PRODUCT CODE: 1884048
The global non-surgical cosmetic procedures market continues its strong upward trajectory as minimally invasive aesthetic treatments gain mainstream acceptance worldwide. According to the latest market insights, the market was valued at USD 11.53 billion in 2024, is projected to rise to USD 12.19 billion in 2025, and is expected to reach USD 18.08 billion by 2032, expanding at a CAGR of 5.8% during the forecast period. Demand continues to rise as individuals increasingly seek aesthetic enhancements that provide visible results with minimal downtime, low risk, and greater affordability compared to surgical options.
In 2024, North America dominated the global market, accounting for 49.60% of total market share. Strong consumer purchasing power, availability of advanced technology, and a large pool of licensed aesthetic practitioners support this leading position. The region also benefits from the rapid introduction of new injectable fillers, toxin treatments, and laser-based skin solutions.
Market Dynamics
Market Drivers
A major driver of market growth is the rising burden of skin disorders such as acne, hyperpigmentation, melasma, and cellulite. These conditions significantly impact self-esteem and appearance, encouraging individuals to opt for minimally invasive cosmetic solutions. For instance, the American Academy of Dermatology reported in February 2025 that acne affects up to 50 million Americans annually, showcasing the immense need for corrective skin treatments.
Furthermore, the number of non-surgical procedures performed globally is rising sharply. According to the International Society of Aesthetic Plastic Surgery, 89,186 Botox procedures and 7,975 chemical peels were performed globally in 2023, reflecting high adoption. Patients increasingly prefer non-invasive treatments like Botox, hyaluronic acid fillers, chemical peels, laser skin rejuvenation, and fat reduction procedures due to faster recovery and minimal complications.
Market Restraints
Despite growth, the market faces restraints linked to side effects and counterfeit cosmetic products. Botox, the most widely performed procedure with around 3 million injections annually, may cause temporary swelling, bruising, pain, and headaches. More severe complications also occur. In April 2024, the CDC reported harmful reactions in 22 women who received counterfeit or mishandled Botox from unlicensed providers, with 11 hospitalized and 6 requiring antitoxin treatment for botulism risks. These safety concerns, along with the illegal import and sale of unauthorized cosmetic injectables, hinder wider market adoption.
Market Opportunities
Growing awareness through direct-to-consumer campaigns has created strong opportunities for market expansion. In April 2025, Evolus Inc. launched its "Drop the F Word" campaign to promote its new Evolysse HA filler collection. Similarly, Allergan Aesthetics' "Own Your Look" Botox campaign reshaped public perception by encouraging natural-looking aesthetic results. These campaigns not only increase awareness but also inspire first-time consumers to explore non-surgical aesthetic treatments.
Market Challenges
High treatment costs remain a significant challenge. As an example, Botox treatments in the U.S. range from USD 100 to USD 2,800, with per-unit costs between USD 10 and USD 18. Similarly, in the U.K., NHS data reports Botox costs ranging from USD 127.7 to USD 447, making these treatments unaffordable for some consumers. These cost disparities push many customers toward medical tourism.
Market Trends
Medical tourism for non-surgical procedures is rising rapidly. Countries like Turkey, Mexico, and Thailand offer Botox treatments at significantly lower costs. In Turkey, the average Botox cost per unit is USD 3-5, compared to USD 15-25 per unit in Europe. Additionally, South Korea attracts over 100,000 medical tourists annually for aesthetic treatments, fueled by K-beauty trends and high-quality clinics.
Botulinum toxin led the market in 2024 due to high adoption for wrinkle reduction. In the U.S. alone, 2.5 million Botox procedures were performed in 2023.
The female segment dominates, accounting for 85.1% of global Botox patients. The 35-50-year age group led demand in 2024, with 4.4 million Botox users, reflecting high aesthetic awareness.
Hospitals and specialty clinics accounted for the largest share in 2024, performing 47.4% of global cosmetic procedures.
North America
North America led the market in 2024 with USD 5.72 billion in revenue. Factors such as strong regulatory frameworks, advanced technology, and large practitioner availability drive regional dominance.
Europe
Europe held the second-largest share, boosted by regulatory steps such as the U.K.'s licensing regime for safer non-surgical cosmetic procedures introduced in 2022.
Asia Pacific
Asia Pacific recorded moderate growth in 2024, driven by growing product launches, such as Juvederm VOLUX in India.
Latin America & Middle East-Africa
Both regions are expanding steadily due to rising procedure volumes, especially in Brazil, where 1.2 million non-surgical procedures were performed in 2023.
Conclusion
Growing from USD 11.53 billion in 2024 to USD 12.19 billion in 2025, and projected to reach USD 18.08 billion by 2032, the global non-surgical cosmetic procedures market is positioned for sustained long-term growth. Increasing aesthetic awareness, advanced technologies, and expanding global access to minimally invasive procedures will continue driving the industry forward.
Segmentation By Procedure
By Gender
By Age Group
By Provider
By Region